Moderate

Ovarian cyst / adnexal mass management

Adnexal mass · Gynaecology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Ovarian cysts are common and mostly benign; management depends on menopausal status, ultrasound features and risk-of-malignancy scoring to distinguish simple cysts needing observation from masses requiring surgery or cancer referral.

Red flags

  • Features suggesting malignancy (solid areas, ascites, high CA125)
  • Acute severe pain suggesting torsion or rupture
  • Postmenopausal complex cyst
  • Rapid growth
  • Weight loss or abdominal distension

Assessment

Differential diagnosis

  • Simple functional cyst
  • Endometrioma
  • Dermoid (mature teratoma)
  • Serous or mucinous cystadenoma
  • Borderline or malignant ovarian tumour
  • Hydrosalpinx or paratubal cyst

Investigations

  • Transvaginal ultrasound describing size, morphology and vascularity
  • CA125 (and the Risk of Malignancy Index or IOTA/ADNEX models)
  • In women under 40, tumour markers (AFP, hCG, LDH) for germ cell tumours
  • CEA/CA19-9 if mucinous or GI source considered
  • CT/MRI for characterisation or staging of suspicious masses

Management

  • Characterise the cyst by ultrasound morphology and size
  • Calculate a risk-of-malignancy score combining menopausal status, ultrasound features and CA125
  • Manage simple cysts under 5 cm in premenopausal women expectantly, as most resolve
  • Follow larger simple cysts with repeat ultrasound over a few months
  • Consider surgery for persistent, large, symptomatic, or complex cysts
  • In postmenopausal women, observe small simple cysts with normal CA125 and refer complex or raised-CA125 masses
  • Refer masses with high risk-of-malignancy scores to gynaecological oncology
  • Prefer laparoscopic cystectomy for benign masses, preserving ovarian tissue in those wanting fertility
  • Counsel on torsion and rupture warning symptoms while awaiting intervention

Drugs & doses

Simple analgesia (paracetamol, NSAIDs) for discomfort
Combined hormonal contraception to reduce new functional cyst formation (not to shrink existing cysts)
No drug treatment shrinks established cysts reliably

Disposition

Primary care surveillance of simple cysts; refer complex or persistent masses to gynaecology, and suspicious masses urgently to gynaecological oncology.

Complications & pitfalls

  • Ovarian torsion
  • Cyst rupture and haemorrhage
  • Malignancy
  • Loss of ovarian reserve after surgery
  • Recurrence

Exam pearls

  • Most simple premenopausal cysts under 5 cm resolve without intervention
  • Use a validated model (RMI or IOTA ADNEX) to triage malignancy risk
  • Combined contraception prevents new functional cysts but does not shrink existing ones
  • A persistently raised CA125 in postmenopausal women with a complex mass warrants oncology referral

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.